Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV Infection
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jenny Yang, PharmD
Gilead Sciences
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
53 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Phoenix, Arizona, United States
- Facility name not stated
Tucson, Arizona, United States
- Facility name not stated
La Jolla, California, United States
- Facility name not stated
Los Angeles, California, United States
- Facility name not stated
Palo Alto, California, United States
- Facility name not stated
San Diego, California, United States
- Facility name not stated
San Francisco, California, United States
- Facility name not stated
Aurora, Colorado, United States
- Facility name not stated
Englewood, Colorado, United States
- Facility name not stated
Washington D.C., District of Columbia, United States
- Facility name not stated
Gainesville, Florida, United States
- Facility name not stated
Jacksonville, Florida, United States
- Facility name not stated
Miami, Florida, United States
- Facility name not stated
Orlando, Florida, United States
- Facility name not stated
Atlanta, Georgia, United States
- Facility name not stated
Marietta, Georgia, United States
- Facility name not stated
Chicago, Illinois, United States
- Facility name not stated
Indianapolis, Indiana, United States
- Facility name not stated
Bowling Green, Kentucky, United States
- Facility name not stated
Baton Rouge, Louisiana, United States
- Facility name not stated
Baltimore, Maryland, United States
- Facility name not stated
Lutherville, Maryland, United States
- Facility name not stated
Boston, Massachusetts, United States
- Facility name not stated
Springfield, Massachusetts, United States
- Facility name not stated
Detroit, Michigan, United States
- Facility name not stated
Rochester, Minnesota, United States
- Facility name not stated
Saint Louis, Minnesota, United States
- Facility name not stated
Saint Paul, Minnesota, United States
- Facility name not stated
Kansas City, Missouri, United States
- Facility name not stated
Berlin, New Jersey, United States
- Facility name not stated
Hillsborough, New Jersey, United States
- Facility name not stated
Albuquerque, New Mexico, United States
- Facility name not stated
Santa Fe, New Mexico, United States
- Facility name not stated
Binghamton, New York, United States
- Facility name not stated
Manhasset, New York, United States
- Facility name not stated
New York, New York, United States
- Facility name not stated
Asheville, North Carolina, United States
- Facility name not stated
Charlotte, North Carolina, United States
- Facility name not stated
Durham, North Carolina, United States
- Facility name not stated
Fayetteville, North Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2013
- Primary completion
- 30 Nov 2013
- Completion
- 28 Feb 2014
- Last update posted
- 16 Nov 2018
- Registered enrollment
- 441
- Registry id
- NCT01768286
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.